The Questionable Rationale Behind the Dow's 111-Point Surge

Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis.

Stocks were in rally mode for a second straight day Friday as Wall Street placed further bets on a debt deal being reached to avoid a U.S. default. Despite the optimism, today's gains are fueled by little more than the willingness of President Obama and GOP conservatives to continue a dialogue. So with the hope of a weekend resolution in the air, the Dow Jones Industrial Average (DJINDICES: ^DJI  ) jumped 111 points, or 0.7%, to end at 15,237. 

Johnson & Johnson (NYSE: JNJ  ) led the Dow higher, adding 1.9%. That's uncharacteristic for shares of the health-care giant: As one of the largest public companies in the world, its stock is hardly volatile. An upgrade from Goldman Sachs spurred today's gains; the banker cited an improved pharmaceutical pipeline as the catalyst. While Johnson & Johnson may not be the most exciting stock to own, it's steady performers like this that helped Warren Buffett become one of the wealthiest individuals in the world. 

Dow newcomer Visa (NYSE: V  ) also ended higher, rising 1.7%. After becoming an official blue chip just last month, the credit card company suddenly plays a leading role in the Dow's performance: Visa now constitutes 8% of the 30-stock index. If the government shutdown finally ends and a default can be avoided, Visa should see improved prospects as government employees get back to work just in time to use their plastic over the holidays.

There were just a handful of Dow decliners today, with agricultural giant DuPont's (NYSE: DD  ) 0.6% loss highlighting the underperformers. Recent years have seen the battle between DuPont and Monsanto intensify as the propagation of genetically modified organisms has spread. The two companies have been taking each other to court for patent disputes and antitrust claims since last year. 

Lastly, Boeing (NYSE: BA  ) shares shed 0.8% pulling back after a nearly 4% surge yesterday. While the company's 56% gains in 2013 are certainly impressive, Boeing's many quality control issues that have popped up this year are disconcerting. From a fire breaking out on a 787 Dreamliner in January to a faulty pump on a 787 in recent weeks, Boeing hasn't been able to stay out of the news for mechanical issues this year.

3 U.S. stocks ripe for global domination
While Boeing's planes can help you get just about anywhere in the world, its stock might not be the best way to capitalize on our interconnectedness. Profiting from our increasingly global economy can be as easy as investing in your own backyard. The Motley Fool's free report "3 American Companies Set to Dominate the World" shows you how. Click here to get your free copy before it's gone.


Read/Post Comments (1) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On October 11, 2013, at 7:38 PM, funfundvierzig wrote:

    "The two companies [Monsanto and DuPont] have been taking each other to court for patent disputes and antitrust claims since last year."

    In the last big patent infringement case in the U. S. District Court of Missouri, a jury awarded Monsanto a $1 billion verdict. After the Judge in the case, Richard Webber, slammed DuPont with fraud sanctions for defrauding not only the court but the media and the public as well, DuPont leaders and their in-house lawyers seemingly felt compelled to settle. Monsanto won big, as DuPont will be shelling out hundreds of $millions to license Monsanto's superior seed technology for years to come.

    As for the spurious anti-trust charges of DuPont's unethical Management and their PR operatives, neither the U. S. Dept. of Justice nor any state's attorney general has gone forward with charges of monopolisation against Monsanto.

    ...funfun..

Add your comment.

DocumentId: 2679767, ~/Articles/ArticleHandler.aspx, 7/30/2014 7:56:09 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement